Open AccessInternational surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use
Author(s) -
S L A M Bronzwaer,
Udo Buchholz,
J. L. Kool
Publication year - 2001
Publication title -
euro surveillance/eurosurveillance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.766
H-Index - 104
eISSN - 1560-7917
pISSN - 1025-496X
DOI - 10.2807/esm.06.01.00225-en
Subject(s) - antibiotic resistance , european union , antimicrobial , methicillin resistant staphylococcus aureus , medicine , antibiotics , staphylococcus aureus , intensive care medicine , drug resistance , resistance (ecology) , environmental health , biology , business , microbiology and biotechnology , international trade , bacteria , genetics , ecology
With travel and trade within the European Union (EU) increasing over the years, the risk of dissemination of (resistant) pathogens grows. Many studies have shown that there is a growing problem with antimicrobial resistance. For example, methicillin resistant Staphylococcus aureus (MRSA) was initially largely a problem of hospitals, but it is now increasingly reported as a community acquired infection. Certain strains have been shown to spread between European countries. Antimicrobial resistance may result in prolonged hospital stay, higher costs, and higher morbidity or even mortality.